\u201cThis study confirms the gut\u2013sleep\u2013brain axis\u2019s role in sleep disorder and depression, demonstrating that circadian misalignment drives gut dysbiosis, impairing sleep architecture and exacerbating depression and anxiety,\u201d wrote researchers from West Bengal State University and other institutions in India and Saudi Arabia.<\/p>\n
The researchers observed that depressive symptoms were linked to lower levels of short-chain fatty acids (SCFAs). They also confirmed the predictive value of microbial metabolites as markers of mental health outcomes, observing that higher levels of tryptophan derivatives such as kynurenine were linked to anxiety.<\/p>\n
\u201cMicrobial byproducts, such as short-chain fatty acids and tryptophan metabolites, are now seen as key messengers in this gut\u2013sleep\u2013brain dialogue, influencing everything from mood to stress resilience,\u201d they wrote, noting the potential for probiotic applications in the treatment of mental illness.<\/p>\n
\u201cWhat is particularly interesting is that this relationship goes both ways: not only does the biological clock influence gut health, but the gut microbiota also appears to impact the body\u2019s internal timing and cognitive functions.\u201d<\/p>\n
Study details<\/p>\n
The randomized controlled trial involved 99 adults with sleep problems and depression and anxiety symptoms who consumed a daily probiotic containing Lactobacillus rhamnosus GG (10B CFU) and Bifidobacterium longum (5B CFU) or placebo for 12 weeks. The researchers instructed the participants to take the capsules between 7 a.m. and 9 a.m. \u201cto coincide with the body\u2019s natural circadian rhythms\u2014specifically, when gut microbial activity tends to peak.\u201d<\/p>\n
Participants also limited their dietary sugar intake to 20 g per day, and a nutritionist monitored compliance.<\/p>\n
Researchers tracked the participants\u2019 sleep using overnight studies and wearable devices, assessed depressive symptoms with questionnaires and used stool samples to analyze gut bacteria and their metabolites. <\/p>\n
They employed \u201cadvanced statistics and machine learning\u201d to pinpoint key microbial factors linked to sleep and mental health. <\/p>\n
Analysis determined that participants with depressive symptoms and disrupted sleep had \u201cfewer beneficial gut bacteria like Bifidobacterium and Lactobacillus, more inflammation-related microbes and lower levels of helpful short-chain fatty acids\u201d at the start of the study.<\/p>\n
After 12 weeks, the researchers reported a statistically significant increase in beneficial bacteria, improved sleep and greater reductions in depression and anxiety scores in the probiotic group compared to the placebo group. <\/p>\n
Pathway analysis showed that \u201ccircadian misalignment predicted gut dysbiosis,\u201d which was linked to sleep disorders and mental health problems. Probiotics treatment enhanced microbial balance and circadian alignment. <\/p>\n
\u201cIncreases in SCFA-producing bacteria most strongly predicted improvements,\u201d the researchers wrote.<\/p>\n
Additionally, the machine learning used assess the predictive value of microbial metabolites as markers of depression and anxiety revealed that butyrate and kynurenine serve as reliable biomarkers, making them potentially useful in precision psychiatry. <\/p>\n
The researchers called for further studies to explore \u201ccircadian-aligned dietary interventions, alongside probiotics, in larger, more diverse populations.\u201d <\/p>\n